H Zhang1, Z W Wang, H B Wu, X P Hu, Z Zhou, P Xu. 1. Department of Cardiothoracic Surgery, Renmin Hospital of Wuhan University, 99 Ziyang Road, 430060, Wuhan, Hubei Province, China.
Abstract
OBJECTIVES: Coronary artery bypass grafting (CABG) is the best therapeutic option for multivessel coronary artery diseases. The internal thoracic artery is usually used for the left anterior descending coronary artery. However, it is still not clear what the best conduit is for non-left anterior descending coronary arteries. This research sought to assess the efficacy of the radial artery versus the saphenous vein in this context. METHODS: A systematic literature search was performed for randomized clinical trials (RCT) published in MEDLINE, EMBASE, and the Cochrane Library. RCTs reporting angiographic comparisons and clinical events of the radial artery versus the saphenous vein were included. RESULTS: Six trials (1,860 participants, 1,188 radial artery grafts, 1,178 saphenous vein grafts) were included in this review. The radial artery was associated with a significantly lower incidence of graft failure (p < 0.05) and of repeat coronary operation (p < 0.05). There was no significant trend toward decreased cardiac death and myocardial infarction with the use of a radial artery (p > 0.05; p > 0.05). As determined by the GRADE method, the evidence quality was low for repeat operation and very low for other variables. CONCLUSION: The radial artery can be weakly recommended as a selective conduit but cannot always be considered better than the saphenous vein.
OBJECTIVES: Coronary artery bypass grafting (CABG) is the best therapeutic option for multivessel coronary artery diseases. The internal thoracic artery is usually used for the left anterior descending coronary artery. However, it is still not clear what the best conduit is for non-left anterior descending coronary arteries. This research sought to assess the efficacy of the radial artery versus the saphenous vein in this context. METHODS: A systematic literature search was performed for randomized clinical trials (RCT) published in MEDLINE, EMBASE, and the Cochrane Library. RCTs reporting angiographic comparisons and clinical events of the radial artery versus the saphenous vein were included. RESULTS: Six trials (1,860 participants, 1,188 radial artery grafts, 1,178 saphenous vein grafts) were included in this review. The radial artery was associated with a significantly lower incidence of graft failure (p < 0.05) and of repeat coronary operation (p < 0.05). There was no significant trend toward decreased cardiac death and myocardial infarction with the use of a radial artery (p > 0.05; p > 0.05). As determined by the GRADE method, the evidence quality was low for repeat operation and very low for other variables. CONCLUSION: The radial artery can be weakly recommended as a selective conduit but cannot always be considered better than the saphenous vein.
Authors: Subodh Verma; Paul E Szmitko; Richard D Weisel; Daniel Bonneau; David Latter; Lee Errett; Yves LeClerc; Stephen E Fremes Journal: Circulation Date: 2004-08-03 Impact factor: 29.690
Authors: Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann Journal: BMJ Date: 2008-04-26
Authors: Steven Goldman; Gulshan K Sethi; William Holman; Hoang Thai; Edward McFalls; Herbert B Ward; Rosemary F Kelly; Birger Rhenman; Gareth H Tobler; Faisal G Bakaeen; Joseph Huh; Ernesto Soltero; Mohammed Moursi; Miguel Haime; Michael Crittenden; Vigneshwar Kasirajan; Michelle Ratliff; Stewart Pett; Anand Irimpen; William Gunnar; Donald Thomas; Stephen Fremes; Thomas Moritz; Domenic Reda; Lynn Harrison; Todd H Wagner; Yajie Wang; Lori Planting; Meredith Miller; Yvette Rodriguez; Elizabeth Juneman; Douglass Morrison; Mary Kaye Pierce; Sandra Kreamer; Mei-Chiung Shih; Kelvin Lee Journal: JAMA Date: 2011-01-12 Impact factor: 56.272
Authors: Brian F Buxton; Jai S Raman; Permyos Ruengsakulrach; Ian Gordon; Alex Rosalion; Rinaldo Bellomo; Mark Horrigan; David L Hare Journal: J Thorac Cardiovasc Surg Date: 2003-06 Impact factor: 5.209